Abstract
There have been no studies that have assessed the possible correlation between conduction abnormality (CA) and systemic embolism, or the long-term outcomes of patients with infective endocarditis (IE). In this study, 82 consecutive patients with IE and interpretable electrocardiography (ECG) were admitted to Kyungpook National University Hospital from July 2002 to June 2008. ECGs obtained at the time of admission or during hospitalization were analyzed. Patients with CA, which was defined as atrioventricular or intraventricular block, of “new” or “of unknown duration” were considered as those with CA. Composite events were defined as the composite of death and embolic events. Twenty-three (28%) patients had CA classified as new (n = 11) or of unknown duration (n = 12). No significant differences were found between patients with and without CA in terms of age and gender. Mean follow-up duration was 21 ± 23 months. Patients with CA had more frequent embolic events (p = 0.001) and composite events (p = 0.002) during hospitalization, and had more frequent composite events (p < 0.001) during follow-up than those without CA. Kaplan–Meier survival curves showed that patients with CA had a higher composite event rate during follow-up (p = 0.003). However, there was no significant difference between the two groups regarding mortality rates during hospitalization and follow-up. In multivariate analysis, CA was an independent predictor of embolic event rates during hospitalization [odds ratio (OR) 5.198, 95% confidence interval (CI) 1.086–24.867, p = 0.039] and of composite event rates during follow-up (OR 27.168, 95% CI 4.590–160.802, p < 0.001). CA is associated with increased frequency of embolic events during hospitalization and follow-up. Moreover, CA might be a useful predictor of embolic event occurrences during both hospitalization and follow-up.
Similar content being viewed by others
References
Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, Levison M, Chambers HF, Dajani AS, Gewitz MH, Newburger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, Ferrieri P (1998) Diagnosis and management of infective endocarditis and its complications. Circulation 98:2936–2948
Meine TJ, Nettles RE, Anderson DJ, Cabell CH, Corey GR, Sexton DJ, Wang A (2001) Cardiac conduction abnormalities in endocarditis defined by the Duke criteria. Am Heart J 142:280–285
Miyamoto MI, Hutter AM Jr, Blum JH, Torchiana DF (1997) Cardiac conduction abnormalities preceding transesophageal echocardiographic evidence of perivalvular extension of infection in a case of salmonella prosthetic valve endocarditis. Heart 78:416–418
Wang K, Gobel F, Gleason DF, Edwards JE (1972) Complete heart block complicating bacterial endocarditis. Circulation 46:939–947
DiNubile MJ, Calderwood SB, Steinhaus DM, Karchmer AW (1986) Cardiac conduction abnormalities complicating native valve active infective endocarditis. Am J Cardiol 58:1213–1217
Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96:200–209
Evangelista A, Gonzalez-Alujas MT (2004) Echocardiography in infective endocarditis. Heart 90:614–617
Mylonakis E, Calderwood SB (2001) Infective endocarditis in adults. N Engl J Med 345:1318–1330
Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann J, Sexton DJ, Corey GR, Wang A (2004) Early predictors of inhospital death in infective endocarditis. Circulation 109:1745–1749
Tissières P, Gervaix A, Beghetti M, Jaeggi ET (2003) Value and limitations of the von Reyn, Duke, and modified Duke criteria for the diagnosis of infective endocarditis in children. Pediatrics 112:e467–e471
Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS (1995) Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess? Chest 107:898–903
Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, Sinha N (2005) Characteristics of infective endocarditis in a developing country—clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol 98:253–260
Mangoni ED, Adinolfi LE, Tripodi MF, Andreana A, Gambardella M, Ragone E, Precone DF, Utili R, Ruggiero G (2003) Risk factors for ‘‘major’’ embolic events in hospitalized patients with infective endocarditis. Am Heart J 146:311–316
Fabri J Jr, Issa VS, Pomerantzeff PM, Grinberg M, Barretto AC, Mansur AJ (2006) Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol 110:334–339
Graupner C, Vilacosta I, San Román JA, Ronderos R, Sarriá C, Fernández C, Mújica R, Sanz O, Sanmartín JV, Pinto AG (2002) Periannular extension of infective endocarditis. J Am Coll Cardiol 39:1204–1211
Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, Kotilainen P (2005) Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 26:1873–1881
De Gennaro L, Brunetti ND, Cuculo A, Pellegrino PL, Di Biase M (2008) Systemic inflammatory in nonischemic dilated cardiomyopathy. Heart Vessels 23:445–450
Crisby M, Kublickiene K, Henareh L, Agewall S (2009) Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart diease. Heart Vessels 24:90–95
Acknowledgements
The authors are deeply indebted to Roberto Patarca, MD, PhD, for his useful suggestions for the preparation of this manuscript. No Grants of any kind were received.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ryu, H.M., Bae, M.H., Lee, S.H. et al. Presence of conduction abnormalities as a predictor of clinical outcomes in patients with infective endocarditis. Heart Vessels 26, 298–305 (2011). https://doi.org/10.1007/s00380-010-0055-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-010-0055-7